ACOR
Closed
Acorda Therapeutics Inc
0.44
+0.44 (0%)
Last Update: 10 May 2024 16:30:00
Yesterday: 0.
Day's Range: 0.4 - 0.68
Send
sign up or login to leave a comment!
When Written:
0.57
Acorda Therapeutics Inc. is a biopharmaceutical company that focuses on developing therapies to treat neurological disorders. The company was founded in 1995 and is headquartered in Ardsley, New York. Acorda's primary product is Ampyra, which is marketed in the United States as a treatment for multiple sclerosis. The company also has several other products in its pipeline, including treatments for Parkinson's disease and spinal cord injury. Acorda has partnerships with several pharmaceutical companies and academic institutions to advance its research and development efforts. The company is publicly traded on the NASDAQ stock exchange under the ticker symbol ACOR.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








